NGF deficiency may trigger spontaneous regression of chemotherapeutic-sensitive RB cells, whereas aggressive RB cells have defective apoptotic machinery, which enables them to evade apoptosis and confers resistance to etoposide treatment [31]. This evidence concerns the gene NGF and retinoblastoma.